Table A2.
Total Number of Deaths by Subtype Among Patients Without Follow-Up at the NCCN Institution in the First 365 Days After Diagnosis
| Tumor Subtype | No. of Deaths After Diagnosis |
No. of Patients Who Were Censored | |
|---|---|---|---|
| In First 365 Days | After the First 365 Days | ||
| HR-positive/HER2-negative | 5 | 35 | 429 |
| HR-positive/HER2-positive | 0 | 0 | 35 |
| HR-negative/HER2-positive | 0 | 0 | 17 |
| HR-negative/HER2-negative | 4 | 9 | 55 |
Abbreviations: HER2, human epidermal growth factor receptor 2; HR, hormone receptor; NCCN, National Comprehensive Cancer Network.